• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

罕见神经疾病中的表观遗传学

Epigenetics in rare neurological diseases.

作者信息

Roberts Chris-Tiann, Arezoumand Khatereh Saei, Kadar Shahib Ashraf, Davie James R, Rastegar Mojgan

机构信息

Department of Biochemistry and Medical Genetics, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada.

出版信息

Front Cell Dev Biol. 2024 Jul 23;12:1413248. doi: 10.3389/fcell.2024.1413248. eCollection 2024.

DOI:10.3389/fcell.2024.1413248
PMID:39108836
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11300358/
Abstract

Rare neurological diseases include a vast group of heterogenous syndromes with primary impairment(s) in the peripheral and/or central nervous systems. Such rare disorders may have overlapping phenotypes, despite their distinct genetic etiology. One unique aspect of rare neurological diseases is their potential common association with altered epigenetic mechanisms. Epigenetic mechanisms include regulatory processes that control gene expression and cellular phenotype without changing the composition of the corresponding DNA sequences. Epigenetic factors include three types of proteins, the "readers, writers, and erasers" of DNA and DNA-bound proteins. Thus, epigenetic impairments of many neurological diseases may contribute to their pathology and manifested phenotypes. Here, we aim to provide a comprehensive review on the general etiology of selected rare neurological diseases, that include Rett Syndrome, Prader-Willi Syndrome, Rubinstein-Taybi Syndrome, Huntington's disease, and Angelman syndrome, with respect to their associated aberrant epigenetic mechanisms.

摘要

罕见神经系统疾病包括一大类异质性综合征,其主要损伤发生在外周和/或中枢神经系统。尽管这些罕见疾病有着不同的遗传病因,但它们可能具有重叠的表型。罕见神经系统疾病的一个独特之处在于其与表观遗传机制改变可能存在的共同关联。表观遗传机制包括在不改变相应DNA序列组成的情况下控制基因表达和细胞表型的调节过程。表观遗传因子包括三种类型的蛋白质,即DNA和与DNA结合的蛋白质的“读取器、写入器和擦除器”。因此,许多神经系统疾病的表观遗传损伤可能导致其病理变化和表现出的表型。在此,我们旨在针对选定的罕见神经系统疾病,包括雷特综合征、普拉德-威利综合征、鲁宾斯坦-泰比综合征、亨廷顿病和天使综合征,就其相关的异常表观遗传机制,提供一篇全面综述。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e97e/11300358/3f84f9f523cd/fcell-12-1413248-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e97e/11300358/eaa0a7babdff/fcell-12-1413248-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e97e/11300358/f852738e0358/fcell-12-1413248-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e97e/11300358/38378de7c74c/fcell-12-1413248-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e97e/11300358/01e2988adc62/fcell-12-1413248-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e97e/11300358/163f5b6e1727/fcell-12-1413248-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e97e/11300358/3f84f9f523cd/fcell-12-1413248-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e97e/11300358/eaa0a7babdff/fcell-12-1413248-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e97e/11300358/f852738e0358/fcell-12-1413248-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e97e/11300358/38378de7c74c/fcell-12-1413248-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e97e/11300358/01e2988adc62/fcell-12-1413248-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e97e/11300358/163f5b6e1727/fcell-12-1413248-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e97e/11300358/3f84f9f523cd/fcell-12-1413248-g006.jpg

相似文献

1
Epigenetics in rare neurological diseases.罕见神经疾病中的表观遗传学
Front Cell Dev Biol. 2024 Jul 23;12:1413248. doi: 10.3389/fcell.2024.1413248. eCollection 2024.
2
Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies.神经疾病中的表观遗传机制:基因、综合征与治疗
Lancet Neurol. 2009 Nov;8(11):1056-72. doi: 10.1016/S1474-4422(09)70262-5.
3
Epigenetic mechanisms of gene expression regulation in neurological diseases.神经疾病中基因表达调控的表观遗传机制。
Acta Neurobiol Exp (Wars). 2013;73(1):19-37. doi: 10.55782/ane-2013-1919.
4
The Epigenetic Reader Methyl-CpG-Binding Protein 2 (MeCP2) Is an Emerging Oncogene in Cancer Biology.表观遗传阅读蛋白甲基化CpG结合蛋白2(MeCP2)是癌症生物学中一种新出现的癌基因。
Cancers (Basel). 2023 May 9;15(10):2683. doi: 10.3390/cancers15102683.
5
Baby food and bedtime: Evidence for opposite phenotypes from different genetic and epigenetic alterations in Prader-Willi and Angelman syndromes.婴儿食品与就寝时间:普拉德-威利综合征和安吉尔曼综合征中不同基因和表观遗传改变导致相反表型的证据。
SAGE Open Med. 2019 Jan 28;7:2050312118823585. doi: 10.1177/2050312118823585. eCollection 2019.
6
MeCP2-Related Diseases and Animal Models.与MeCP2相关的疾病及动物模型
Diseases. 2014 Jan 27;2(1):45-70. doi: 10.3390/diseases2010045.
7
Epigenetics and Bruxism: Possible Role of Epigenetics in the Etiology of Bruxism.表观遗传学与磨牙症:表观遗传学在磨牙症病因学中的可能作用。
Int J Prosthodont. 2015 Nov-Dec;28(6):594-9. doi: 10.11607/ijp.4126.
8
Editorial: Epigenetic Mechanisms and Their Involvement in Rare Diseases.社论:表观遗传机制及其在罕见病中的作用
Front Genet. 2021 Sep 1;12:755076. doi: 10.3389/fgene.2021.755076. eCollection 2021.
9
Epigenetics, autism spectrum, and neurodevelopmental disorders.表观遗传学、自闭症谱系和神经发育障碍。
Neurotherapeutics. 2013 Oct;10(4):742-56. doi: 10.1007/s13311-013-0227-0.
10
MeCP2 deficiency in Rett syndrome causes epigenetic aberrations at the PWS/AS imprinting center that affects UBE3A expression.雷特综合征中MeCP2缺乏会导致普拉德-威利综合征/安吉尔曼综合征印记中心的表观遗传异常,从而影响UBE3A的表达。
Hum Mol Genet. 2005 Apr 15;14(8):1049-58. doi: 10.1093/hmg/ddi097. Epub 2005 Mar 9.

引用本文的文献

1
Mutation of MeCP2 at T158M Leads to Distinct Molecular and Phenotypic Abnormalities in Male and Female Mice.甲基化CpG结合蛋白2(MeCP2)T158M位点的突变导致雄性和雌性小鼠出现不同的分子和表型异常。
Cells. 2025 Aug 19;14(16):1286. doi: 10.3390/cells14161286.
2
Molecular Insights into Neurological Regression with a Focus on Rett Syndrome-A Narrative Review.聚焦雷特综合征的神经退行性变的分子见解——一篇叙述性综述
Int J Mol Sci. 2025 Jun 3;26(11):5361. doi: 10.3390/ijms26115361.
3
Genetics and Epigenetics of Human Pubertal Timing: The Contribution of Genes Associated With Central Precocious Puberty.

本文引用的文献

1
Novel SETBP1 D874V adjacent to the degron causes canonical schinzel-giedion syndrome: a case report and review of the literature.新型 SETBP1 D874V 临近降解结构域导致经典型 Schinzel-Giedion 综合征:病例报告及文献复习。
BMC Pediatr. 2024 May 6;24(1):309. doi: 10.1186/s12887-024-04779-y.
2
Extending MeCP2 interactome: canonical nucleosomal histones interact with MeCP2.扩展MeCP2相互作用组:典型核小体组蛋白与MeCP2相互作用。
Nucleic Acids Res. 2024 Apr 24;52(7):3636-3653. doi: 10.1093/nar/gkae051.
3
Transcriptional Inhibition of the Mecp2 Promoter by MeCP2E1 and MeCP2E2 Isoforms Suggests Negative Auto-Regulatory Feedback that can be Moderated by Metformin.
人类青春期发育时间的遗传学与表观遗传学:与中枢性性早熟相关基因的作用
J Endocr Soc. 2025 Jan 21;9(2):bvae228. doi: 10.1210/jendso/bvae228. eCollection 2025 Jan 6.
4
Diverse Applications of the Anti-Diabetic Drug Metformin in Treating Human Disease.抗糖尿病药物二甲双胍在治疗人类疾病中的多种应用。
Pharmaceuticals (Basel). 2024 Nov 27;17(12):1601. doi: 10.3390/ph17121601.
MeCP2E1 和 MeCP2E2 同工型对 Mecp2 启动子的转录抑制提示存在负反馈自我调节,这种调节可被二甲双胍所调控。
J Mol Neurosci. 2024 Jan 26;74(1):14. doi: 10.1007/s12031-023-02177-0.
4
The landscape of SETBP1 gene expression and transcription factor activity across human tissues.人类组织中 SETBP1 基因表达和转录因子活性的全景图。
PLoS One. 2024 Jan 2;19(1):e0296328. doi: 10.1371/journal.pone.0296328. eCollection 2024.
5
Mutant-Huntingtin Molecular Pathways Elucidate New Targets for Drug Repurposing.突变型亨廷顿蛋白分子通路解析为药物重定位提供新靶点。
Int J Mol Sci. 2023 Nov 27;24(23):16798. doi: 10.3390/ijms242316798.
6
MeCP2 is the protector of epigenome integrity, membrane-less nuclear architecture, and stability of chromatin assembly.MeCP2 是基因组表观完整性、无膜核架构和染色质组装稳定性的保护者。
Epigenomics. 2023 Oct;15(20):1027-1031. doi: 10.2217/epi-2023-0310. Epub 2023 Nov 8.
7
Identification of molecular signatures and pathways involved in Rett syndrome using a multi-omics approach.采用多组学方法鉴定雷特综合征相关的分子特征和途径。
Hum Genomics. 2023 Sep 15;17(1):85. doi: 10.1186/s40246-023-00532-1.
8
Presynaptic Ube3a E3 ligase promotes synapse elimination through down-regulation of BMP signaling.突触前 Ube3a E3 连接酶通过下调 BMP 信号促进突触消除。
Science. 2023 Sep 15;381(6663):1197-1205. doi: 10.1126/science.ade8978. Epub 2023 Sep 14.
9
The impact of SETBP1 mutations in neurological diseases and cancer.SETBP1 突变在神经疾病和癌症中的影响。
Genes Cells. 2023 Sep;28(9):629-641. doi: 10.1111/gtc.13057. Epub 2023 Jul 25.
10
Balanced SET levels favor the correct enhancer repertoire during cell fate acquisition.平衡的 SET 水平有利于细胞命运获得过程中正确的增强子谱。
Nat Commun. 2023 Jun 3;14(1):3212. doi: 10.1038/s41467-023-39043-x.